Associate Director, Biostatistics
bluebird bio, Inc, Massachusetts, United States
Disclosure information not submitted.
Lovotibeglogene Autotemcel Gene Therapy For Sickle Cell Disease: 60 Months Follow-Up
Saturday, June 8, 2024
8:45 AM – 9:00 AM ET